相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Tamara K. Berthoud et al.
CLINICAL INFECTIOUS DISEASES (2011)
Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutinin
Saleem Basha et al.
HUMAN IMMUNOLOGY (2011)
Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells
Marine L. B. Hillaire et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Seasonal FluMist Vaccination Induces Cross-Reactive T Cell Immunity against H1N1 (2009) Influenza and Secondary Bacterial Infections
Keer Sun et al.
JOURNAL OF IMMUNOLOGY (2011)
T Cell-Mediated Protection against Lethal 2009 Pandemic H1N1 Influenza Virus Infection in a Mouse Model
Hailong Guo et al.
JOURNAL OF VIROLOGY (2011)
Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets
R. Bodewes et al.
JOURNAL OF VIROLOGY (2011)
Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity
Annett Hessel et al.
PLOS ONE (2011)
Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
Jae-Min Song et al.
PLOS ONE (2011)
Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine
Grace L. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Lessons from pandemic influenza A(H1N1): The research-based vaccine industry's perspective
Atika Abelin et al.
VACCINE (2011)
Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV)
Isaac Sipo et al.
VACCINE (2011)
Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4+ T cells against the swine-origin H1N1 influenza virus
Brian C. Schanen et al.
VACCINE (2011)
H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals
Dong-Hun Lee et al.
VACCINE (2011)
Production of adenovirus vectors and their use as a delivery system for influenza vaccines
Sai V. Vemula et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Cross-protective immunity to influenza A viruses
Suzanne L. Epstein et al.
EXPERT REVIEW OF VACCINES (2010)
Generation of effector CD8+T cells and their conversion to memory T cells
Weiguo Cui et al.
IMMUNOLOGICAL REVIEWS (2010)
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
Davide Corti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model
Joost H. C. M. Kreijtz et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus
Ioanna Skountzou et al.
JOURNAL OF IMMUNOLOGY (2010)
Immunization with Live Attenuated Influenza Viruses That Express Altered NS1 Proteins Results in Potent and Protective Memory CD8+ T-Cell Responses
Scott N. Mueller et al.
JOURNAL OF VIROLOGY (2010)
Cytotoxic T Cells Are the Predominant Players Providing Cross-Protective Immunity Induced by γ-Irradiated Influenza A Viruses
Yoichi Furuya et al.
JOURNAL OF VIROLOGY (2010)
Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-React against 2009 Pandemic H1N1 Influenza Virus
Wenwei Tu et al.
JOURNAL OF VIROLOGY (2010)
New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets
Robert H. E. Friesen et al.
PLOS ONE (2010)
A Candidate H1N1 Pandemic Influenza Vaccine Elicits Protective Immunity in Mice
Julia Steitz et al.
PLOS ONE (2010)
Cross- reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses
Stephanie Gras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
Taia T. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Chih-Jen Wei et al.
SCIENCE (2010)
Report of the fourth meeting on 'Influenza vaccines that induce broad spectrum and long-lasting immune responses', World Health Organization and Wellcome Trust, London, United Kingdom, 9-10 November 2009
Iain Stephenson et al.
VACCINE (2010)
Baculovirus as an avian influenza vaccine vector: Differential immune responses elicited by different vector forms
Chi-Yuan Chen et al.
VACCINE (2010)
Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin
Larry R. Smith et al.
VACCINE (2010)
Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8+ T lymphocytes
Shailbala Singh et al.
VIROLOGY (2010)
Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
John Steel et al.
MBIO (2010)
Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice
Pan Tao et al.
ANTIVIRAL RESEARCH (2009)
Recombinant Vesicular Stomatitis Virus Expressing Influenza Nucleoprotein Induces CD8 T-Cell Responses That Enhance Antibody-Mediated Protection after Lethal Challenge with Influenza Virus
Brice E. Barefoot et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara
Guus F. Rimmelzwaan et al.
EXPERT REVIEW OF VACCINES (2009)
Baculovirus vector as a delivery vehicle for influenza vaccines
Fang He et al.
EXPERT REVIEW OF VACCINES (2009)
A Live Attenuated H1N1 M1 Mutant Provides Broad Cross-Protection against Influenza A Viruses, Including Highly Pathogenic A/Vietnam/1203/2004, in Mice
Hang Xie et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
A Trivalent Virus-Like Particle Vaccine Elicits Protective Immune Responses against Seasonal Influenza Strains in Mice and Ferrets
Ted M. Ross et al.
PLOS ONE (2009)
MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
Joost H. C. M. Kreijtz et al.
PLOS ONE (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge
Brice E. Barefoot et al.
VACCINE (2009)
Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses
J. H. C. M. Kreijtz et al.
VACCINE (2009)
Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus
J. H. C. M. Kreijtz et al.
VACCINE (2009)
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals
Laurel Yong-Hwa Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus
Michelle Roti et al.
JOURNAL OF IMMUNOLOGY (2008)
A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus
Damian M. Carragher et al.
JOURNAL OF IMMUNOLOGY (2008)
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses
Mary A. Hoelscher et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza a virus
J. H. C. M. Kreijtz et al.
JOURNAL OF VIROLOGY (2008)
Heterosubtypic immunity to influenza A virus: where do we stand?
Kristie M. Grebe et al.
MICROBES AND INFECTION (2008)
Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens
Dominick J. Laddy et al.
PLOS ONE (2008)
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
Mark Throsby et al.
PLOS ONE (2008)
Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses
David H. Holman et al.
VACCINE (2008)
BLD cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms
Javier Rangel-Moreno et al.
JOURNAL OF IMMUNOLOGY (2008)
New pre-pandemic influenza vaccines: An egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice
M. A. Hoelscher et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein
Soumitra Roy et al.
VACCINE (2007)
The loss of immunodominant epitopes affects interferon-γ production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro
E. G. M. Berkhoff et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones
E. G. M. Berkhoff et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus
Timothy J. Powell et al.
JOURNAL OF IMMUNOLOGY (2007)
Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice
J. H. C. M. Kreijtz et al.
VACCINE (2007)
Avian influenza A (H5N1) age distribution in humans
Matthew Smallman-Raynor et al.
EMERGING INFECTIOUS DISEASES (2007)
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1
Stephen Mark Tompkins et al.
EMERGING INFECTIOUS DISEASES (2007)
Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
Xiao-Song He et al.
JOURNAL OF VIROLOGY (2006)
Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses
E. G. M. Berkhoff et al.
VACCINE (2006)
The virosomal influenza vaccine Invivac®:: Immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad®) in elderly subjects
I. A. de Bruijn et al.
VACCINE (2006)
Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses
Xiuhua Lu et al.
VACCINE (2006)
A fused gene of nucleoprotein (NIP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus
Sukumar Saha et al.
VIROLOGY (2006)
Confronting complexity:: Real-world immunodominance in antiviral CD8+ T cell responses
Jonathan W. Yewdell
IMMUNITY (2006)
From plasmids to protection: A review of DNA vaccines against infectious diseases
Dominick J. Laddy et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2006)
Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge
CC Breathnach et al.
VACCINE (2006)
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
MA Hoelscher et al.
LANCET (2006)
Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization
WT Gao et al.
JOURNAL OF VIROLOGY (2006)
Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: An experiment of nature
SL Epstein
JOURNAL OF INFECTIOUS DISEASES (2006)
Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes
EGM Berkhoff et al.
JOURNAL OF VIROLOGY (2005)
Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants
GF Rimmelzwaan et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Dendritic cells maximize the memory CD8 T cell response to infection
DJ Zammit et al.
IMMUNITY (2005)
Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge
JM Galarza et al.
VIRAL IMMUNOLOGY (2005)
Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity
L Bungener et al.
VACCINE (2005)
Influenza a vaccine based on the extracellular domain of M2: Weak protection mediated via antibody-dependent NK cell activity
A Jegerlehner et al.
JOURNAL OF IMMUNOLOGY (2004)
Preferential HLA usage in the influenza virus-specific CTL response
ACM Boon et al.
JOURNAL OF IMMUNOLOGY (2004)
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes
ACM Boon et al.
JOURNAL OF IMMUNOLOGY (2004)
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
JA Fan et al.
VACCINE (2004)
Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza A viruses by comutations
GF Rimmelzwaan et al.
JOURNAL OF VIROLOGY (2004)
Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes
GF Rimmelzwaan et al.
VIRUS RESEARCH (2004)
Reversal in the immunodominance hierarchy in secondary CD8+ T cell responses to influenza A virus:: Roles for cross-presentation and lysis-independent immunodomination
W Chen et al.
JOURNAL OF IMMUNOLOGY (2004)
A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte -: Response in vitro
EGM Berkhoff et al.
JOURNAL OF VIROLOGY (2004)
A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice
NR Donelan et al.
JOURNAL OF VIROLOGY (2003)
Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A
JR Gog et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Heat-aggregated noninfectious influenza virus induces a more balanced CD8+-T-lymphocyte immunodominance hierarchy than infectious virus
Y Cho et al.
JOURNAL OF VIROLOGY (2003)
In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens
S Jung et al.
IMMUNITY (2002)
Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus
PP Heinen et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Virosome-mediated delivery of protein antigens to dendritic cells
L Bungener et al.
VACCINE (2002)
Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-Like H5N1 influenza virus is correlated with the proportion of pulmonary CD8+ T cells expressing gamma interferon
SH Seo et al.
JOURNAL OF VIROLOGY (2002)
The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype
ACM Boon et al.
JOURNAL OF VIROLOGY (2002)
Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza a virus nucleoprotein associated with escape from cytotoxic T lymphocytes
ACM Boon et al.
JOURNAL OF VIROLOGY (2002)
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function
S Sambhara et al.
CELLULAR IMMUNOLOGY (2001)
Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells
KA Benton et al.
JOURNAL OF IMMUNOLOGY (2001)
Cutting edge: Recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells
SA Prasad et al.
JOURNAL OF IMMUNOLOGY (2001)
Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets
SH Seo et al.
JOURNAL OF VIROLOGY (2001)
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes
HH Nguyen et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM™ vaccines and conventional vaccines
GF Rimmelzwaan et al.
VACCINE (2000)
Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon
XY Wang et al.
JOURNAL OF VIROLOGY (2000)
Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice
E O'Neill et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8+ cytotoxic T lymphocytes
JTM Voeten et al.
VACCINE (2000)
Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses
GT Belz et al.
JOURNAL OF IMMUNOLOGY (2000)
Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes
JTM Voeten et al.
JOURNAL OF VIROLOGY (2000)
A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge
GT Belz et al.
JOURNAL OF VIROLOGY (2000)
分享论文
